Wikidata |

Wikidata

Matches in Wikidata for { <http://www.wikidata.org/entity/Q37346570> ?p ?o ?g. }

Showing items 1 to 100 of ±164 with 100 items per page.

Q37346570 description "article científic" @default.
Q37346570 description "article scientifique" @default.
Q37346570 description "articolo scientifico" @default.
Q37346570 description "artigo científico" @default.
Q37346570 description "artículu científicu espublizáu en 2009" @default.
Q37346570 description "bilimsel makale" @default.
Q37346570 description "scientific article published on 18 August 2009" @default.
Q37346570 description "vedecký článok" @default.
Q37346570 description "vetenskaplig artikel" @default.
Q37346570 description "videnskabelig artikel" @default.
Q37346570 description "vědecký článek" @default.
Q37346570 description "wetenschappelijk artikel" @default.
Q37346570 description "wissenschaftlicher Artikel" @default.
Q37346570 description "наукова стаття, опублікована в серпні 2009" @default.
Q37346570 description "научни чланак" @default.
Q37346570 description "مقالة علمية نشرت في 18 أغسطس 2009" @default.
Q37346570 name "mTOR is a promising therapeutic target both in cisplatin-sensitive and cisplatin-resistant clear cell carcinoma of the ovary" @default.
Q37346570 name "mTOR is a promising therapeutic target both in cisplatin-sensitive and cisplatin-resistant clear cell carcinoma of the ovary" @default.
Q37346570 name "mTOR is a promising therapeutic target both in cisplatin-sensitive and cisplatin-resistant clear cell carcinoma of the ovary" @default.
Q37346570 type Item @default.
Q37346570 label "mTOR is a promising therapeutic target both in cisplatin-sensitive and cisplatin-resistant clear cell carcinoma of the ovary" @default.
Q37346570 label "mTOR is a promising therapeutic target both in cisplatin-sensitive and cisplatin-resistant clear cell carcinoma of the ovary" @default.
Q37346570 label "mTOR is a promising therapeutic target both in cisplatin-sensitive and cisplatin-resistant clear cell carcinoma of the ovary" @default.
Q37346570 prefLabel "mTOR is a promising therapeutic target both in cisplatin-sensitive and cisplatin-resistant clear cell carcinoma of the ovary" @default.
Q37346570 prefLabel "mTOR is a promising therapeutic target both in cisplatin-sensitive and cisplatin-resistant clear cell carcinoma of the ovary" @default.
Q37346570 prefLabel "mTOR is a promising therapeutic target both in cisplatin-sensitive and cisplatin-resistant clear cell carcinoma of the ovary" @default.
Q37346570 P1433 Q37346570-1E945508-5CF9-405A-ACD5-1E0DD6D2E138 @default.
Q37346570 P1476 Q37346570-28E45FE4-786B-4F2F-83B8-9032AE55BB9F @default.
Q37346570 P2093 Q37346570-18F1E626-ED75-4969-8433-C8161A11DC69 @default.
Q37346570 P2093 Q37346570-3E21F0FD-CA7E-4287-8114-7DCFFB60F008 @default.
Q37346570 P2093 Q37346570-8B14D934-5395-43F9-9735-9EBFDC804F15 @default.
Q37346570 P2093 Q37346570-9D72DB67-AECA-4D70-97F2-26FEBBA441CF @default.
Q37346570 P2860 Q37346570-06E54DAB-AF99-4C6F-9F25-6AFD62F5A5D1 @default.
Q37346570 P2860 Q37346570-07CAC4B3-207E-4D4C-85B5-2D393D311754 @default.
Q37346570 P2860 Q37346570-08511504-E7E3-4872-8520-CAB626DEDF95 @default.
Q37346570 P2860 Q37346570-0A8CF4BD-70E8-4F11-B037-A61A86F81720 @default.
Q37346570 P2860 Q37346570-116F4087-8408-4E6E-8BAF-89AF5397AD07 @default.
Q37346570 P2860 Q37346570-14B77DB7-531B-49D1-85AF-6ED336CD8C54 @default.
Q37346570 P2860 Q37346570-18DAF255-4B0F-4B6A-AFA8-7DB73D950270 @default.
Q37346570 P2860 Q37346570-222F1307-DEF9-4184-89C5-F358740009C4 @default.
Q37346570 P2860 Q37346570-2F49AC73-6C1A-4B34-946C-5B46409D59B9 @default.
Q37346570 P2860 Q37346570-3CFD0E0C-F38C-4B78-AF00-3243F0433D05 @default.
Q37346570 P2860 Q37346570-402AB641-8B39-42E2-8877-23667CD78C52 @default.
Q37346570 P2860 Q37346570-46643C31-11C0-4790-82F5-7F254834291D @default.
Q37346570 P2860 Q37346570-4C82B9C3-C520-4AD1-AA82-7709082E8DBF @default.
Q37346570 P2860 Q37346570-4DBF48AD-3FDE-4C2C-BF3F-3DDBF3C4D0A8 @default.
Q37346570 P2860 Q37346570-510B7435-FF56-4D7D-A2CE-9B8752DEEDE3 @default.
Q37346570 P2860 Q37346570-5900FBC0-0042-4886-A688-65EB9549CE4B @default.
Q37346570 P2860 Q37346570-68A13D37-09D9-4EA6-9279-B127C20CD2F6 @default.
Q37346570 P2860 Q37346570-6A4A072B-DCE1-4BBB-AEF7-83E2B34AD3E6 @default.
Q37346570 P2860 Q37346570-6DEBE0F0-0ACC-46C3-83BD-5EB0EAEAEB13 @default.
Q37346570 P2860 Q37346570-75D3F40B-820D-4AD4-B556-936C36248F95 @default.
Q37346570 P2860 Q37346570-7DBC00B8-4AE9-484F-B6CF-335A00263ABD @default.
Q37346570 P2860 Q37346570-814246F2-11E3-4144-8BA8-CC269BF52AF7 @default.
Q37346570 P2860 Q37346570-83337101-DCFD-4286-9D71-F8F04700F205 @default.
Q37346570 P2860 Q37346570-84AAE2DE-ACAB-4420-AC4A-3884ED0A0537 @default.
Q37346570 P2860 Q37346570-8D06A45B-5CE0-45E4-9B2A-C0F76E1B0A03 @default.
Q37346570 P2860 Q37346570-A0468D5D-DE1F-4E6C-B693-AD5269910EA8 @default.
Q37346570 P2860 Q37346570-A93E4251-CD92-49F2-A430-50A19593B133 @default.
Q37346570 P2860 Q37346570-AB584AD1-ACEB-4979-BC0B-A4DA5BC0DC99 @default.
Q37346570 P2860 Q37346570-B22B231B-EEBD-4A43-BAF6-5DAA21E943F3 @default.
Q37346570 P2860 Q37346570-B3BF6830-2CF3-4149-9CB5-100A20D5F81C @default.
Q37346570 P2860 Q37346570-B69D9A95-3B58-45D0-86E5-3E6339F6CC49 @default.
Q37346570 P2860 Q37346570-BBFE73FA-B1EB-429B-9975-1D4631960D82 @default.
Q37346570 P2860 Q37346570-C2E4A58B-2BE9-4CBE-A026-F0DF0B4060AA @default.
Q37346570 P2860 Q37346570-C3B47F1D-9E7D-434C-9980-DE9B46579DE9 @default.
Q37346570 P2860 Q37346570-CD251037-4DF2-4405-BAD1-59FC57B73829 @default.
Q37346570 P2860 Q37346570-D0DF7C87-F881-4D7D-A7E8-B844A4E8B044 @default.
Q37346570 P2860 Q37346570-D42C29A9-6B32-4528-A980-2F4587B74C03 @default.
Q37346570 P2860 Q37346570-D9E8A83F-4378-4355-A5A8-EEB9F5E1D50F @default.
Q37346570 P2860 Q37346570-DC047642-7E69-45C8-85C5-194F92B61C29 @default.
Q37346570 P2860 Q37346570-E150533B-8243-47E6-B809-DB72D57C7919 @default.
Q37346570 P2860 Q37346570-E1A31E94-C790-4E12-B7D9-8ED2BE7ED0A0 @default.
Q37346570 P2860 Q37346570-FB5C740D-3591-456B-A76C-68F80D1C271A @default.
Q37346570 P304 Q37346570-F088321C-B407-4048-A946-9F77CFB0E8A6 @default.
Q37346570 P31 Q37346570-8C48975E-E960-4A65-9273-521EBA66620A @default.
Q37346570 P356 Q37346570-21BFA4B1-B45D-403B-B066-2DD5C11C42CC @default.
Q37346570 P407 Q37346570-60B1A93D-7774-429E-A69D-069449C06047 @default.
Q37346570 P433 Q37346570-984F4D98-BF3E-48C8-AF35-B819FB0A75FE @default.
Q37346570 P478 Q37346570-99A75C63-F5A4-42A7-A35B-86669F055ED7 @default.
Q37346570 P50 Q37346570-15EED3A8-530E-4799-AD53-1714A1E464A2 @default.
Q37346570 P50 Q37346570-3829E17F-89C4-48CF-B553-9D5DED528612 @default.
Q37346570 P50 Q37346570-4C775FE4-AB4B-480C-9022-694AC013D750 @default.
Q37346570 P50 Q37346570-54B1299D-DAF1-4E83-A17B-89D22A0E5B4A @default.
Q37346570 P50 Q37346570-73BF80E7-7300-40AA-BCFE-B37E8745B799 @default.
Q37346570 P50 Q37346570-80492F31-F129-4FEF-B79B-899AB656887C @default.
Q37346570 P50 Q37346570-A8BD6EC2-7D97-4796-92F7-EF05FAE3D314 @default.
Q37346570 P50 Q37346570-E1446A63-7784-404E-B886-0838380B0F41 @default.
Q37346570 P50 Q37346570-F81C0671-64F9-48B6-9F34-397E84B5E2EB @default.
Q37346570 P577 Q37346570-3292B1A7-45F2-439C-95E1-0B235C75392B @default.
Q37346570 P698 Q37346570-CB63E6E6-99E0-4389-8530-5A223F93817A @default.
Q37346570 P921 Q37346570-C6796B1B-429C-4A14-91E6-993ED6BD6ED5 @default.
Q37346570 P921 Q37346570-D7A07E71-CB18-4382-A574-820B1E33DE0F @default.
Q37346570 P932 Q37346570-631A5E25-BC3A-4B00-BDA0-8476A1E5DC0F @default.
Q37346570 P356 1078-0432.CCR-09-0365 @default.
Q37346570 P698 19690197 @default.
Q37346570 P1433 Q332253 @default.
Q37346570 P1476 "mTOR is a promising therapeutic target both in cisplatin-sensitive and cisplatin-resistant clear cell carcinoma of the ovary" @default.
Q37346570 P2093 "Mareo Yamoto" @default.
Q37346570 P2093 "Masahiko Tsujimoto" @default.